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Introduction
Pneumococcal disease is a preventable cause of morbidity
and mortality. It can lead to pneumonia, bacteremia and
meningitis. S. pneumonia infection is the most common
cause of community acquired pneumonia worldwide1.
The common serotypes isolated were all covered by the
pneumococcal vaccine. Smokers, patients with heart dis-
ease, asthma, COPD, diabetes mellitus, alcoholism, liver
cirrhosis as well as the immunocompromised are at a
greater risk and should be vaccinated. All adults aged
65 years and older should also get the adult Pneumococ-
cal vaccine as long as it has been 5 years since the pre-
vious dose and they have no contraindications2.
Objectives
To increase uptake of adult Pneumococcal vaccination
rates in patients with Asthma and COPD in Bukit
Batok Polyclinic from September to November 2013 to
at least 10%.
Methods
All patient visits coded with the Diagnoses “Asthma”
and/or “COPD” in the months of May-November 2013
were retrieved from the clinic database with the help of
our clinic operations executive and IT support staff.
Those who were administered the adult Pneumococcal
vaccine (PPSV23) vaccine in these months were identi-
fied. Patients who were less than 19 years old, or were
already previously vaccinated were excluded. A root
cause analysis showed multiple physician, system and
patient factors. Appropriate interventions were put in
place and the vaccination rates were reassessed.
Results
The results showed an improvement in uptake rates
with the highest rate of 5.99% in October 2013.
Conclusion
Physician recommendation and increasing patient aware-
ness of the vaccine were effective in increasing uptake
rates. Doctors should target suitable patients for vaccina-
tion in every doctor-patient contact, dispel misconcep-
tions, offer information and provide adequate counselling
about the risks and benefits of the vaccine. Electronic
prompting to remind physicians to offer vaccinations and
clinical audit of immunisation rates is likely to be an effec-
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